about
The gastric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intakeFNDC5/irisin is not only a myokine but also an adipokineLeptin resistance in obesity: An epigenetic landscape.A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis.Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index.Modulation of Higher-Order Olfaction Components on Executive Functions in Humans.Genome-Wide DNA Methylation Analysis Identifies Novel Hypomethylated Non-Pericentromeric Genes with Potential Clinical Implications in ICF Syndrome.Changes in Body Composition in Anorexia Nervosa: Predictors of Recovery and Treatment OutcomeDecision Making Impairment: A Shared Vulnerability in Obesity, Gambling Disorder and Substance Use Disorders?"Food Addiction" in Patients with Eating Disorders is Associated with Negative Urgency and Difficulties to Focus on Long-Term Goals.Modulation of Irisin and Physical Activity on Executive Functions in Obesity and Morbid obesity.Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitusEpigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer.Obestatin as a regulator of adipocyte metabolism and adipogenesis.Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects.DNA methylation map in circulating leukocytes mirrors subcutaneous adipose tissue methylation pattern: a genome-wide analysis from non-obese and obese patients.Ghrelin as a GH-releasing factor.Irisin: 'fat' or artefact.Obesity and the reproductive system disorders: epigenetics as a potential bridge.Regulation of Growth Hormone by the Splanchnic Area.Obesity and menopause modify the epigenomic profile of breast cancer.Secreted factors derived from obese visceral adipose tissue regulate the expression of breast malignant transformation genes.Genome-wide DNA methylation pattern in visceral adipose tissue differentiates insulin-resistant from insulin-sensitive obese subjects.Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis Fungoides.Interaction Between Orexin-A and Sleep Quality in Females in Extreme Weight Conditions.Obesity and the future. New problems and new solutions.The obestatin/GPR39 system is up-regulated by muscle injury and functions as an autocrine regenerative system.Translating cancer epigenomics into the clinic: focus on lung cancer.Acid-base safety during the course of a very low-calorie-ketogenic dietPreproghrelin expression is a key target for insulin action on adipogenesis.Age, sex, and lactating status regulate ghrelin secretion and GOAT mRNA levels from isolated rat stomach.Expression of two inflammation-related genes (RIPK3 and RNF216) in mononuclear cells is associated with weight-loss regain in obese subjects.Body Composition Changes After Very-Low-Calorie Ketogenic Diet in Obesity Evaluated by 3 Standardized Methods.Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women.Inflammatory state and stress condition in weight-lowering Lys109Arg LEPR gene polymorphism carriers.Tachyphylaxis effects on postprandial oxidative stress and mitochondrial-related gene expression in overweight subjects after a period of energy restriction.Energy restriction in obese subjects impact differently two mitochondrial function markers.Pre-treatment circulating leptin/ghrelin ratio as a non-invasive marker to identify patients likely to regain the lost weight after an energy restriction treatment.Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients.A nutrigenomic inflammation-related PBMC-based approach to predict the weight-loss regain in obese subjects.
P50
Q27301993-DB4918F6-0F77-4A4F-8DEC-954842582B42Q27329974-1BEF0B8B-E8E4-4E1E-82CC-E0973F22A361Q30374882-B78C7F2A-B884-4121-A1CC-03B2CB6A8F61Q30384899-DC29E4E7-20D1-46A2-9D65-58FB7E2CB539Q33594246-76489EA0-BD7A-4CDC-8584-790AD85D49D4Q35666060-40890E60-C5F7-4D7B-86B6-DE3221E08F58Q35688081-3D7AAED0-9462-43E8-8C2E-D09189FE7926Q35850797-B05C6780-6649-42D4-B9D1-C24CA6F780BAQ36150020-A4DEC80F-02DA-40DE-8054-F121EB11E5F1Q36528204-C6D4A7B1-44FC-4C82-80FA-1BFD9EE13E77Q37141128-7EA05AA7-F677-47E7-B407-00DB46AE988BQ37306677-F4083FCB-1BB8-4D9A-944F-033D67D22079Q37451300-2AB58750-ED8C-4F13-8C65-014C09E0C957Q37568650-B12497F6-2CAF-4C34-8B41-20C68FF61092Q37614479-3BEC6667-40F4-4991-8F7A-35CA00901BB6Q37649597-B0F40978-3356-4130-9593-32CA8A2075F5Q38104900-EC4E815E-8138-4381-9D54-0D922C0AFE84Q38257169-429D324A-04C8-4BA1-B74A-0F68634C143EQ38270080-29668A6B-1C49-4D8B-AD63-FBEDCF7385EAQ38759719-A72D4123-CCBC-488F-A217-78C1926168F1Q38820115-0EF0B7CF-3BDB-4504-9229-CB362E98CAE0Q38829862-E1B32256-DF37-4394-91F2-05B86751378BQ38835938-C80404A7-083C-4E90-A519-1624E447D185Q38841334-FD295727-475D-4A86-8C1E-E4D48DEB8FA8Q39244986-616748A9-3D25-489B-811D-1A32B644EDD7Q39257744-33C8CC5F-5710-4EA9-8DA9-24C9131AE8CDQ39275635-9D2DC98B-C86D-4D6E-B96F-FED8D2A5E1CBQ39394558-AF0A72FF-FB9A-4DFF-AAFC-9B1EF1D18DD3Q42362307-EF22E249-2CC8-408F-A596-D7497A053F1DQ42809106-A6C0BF84-1D43-4F13-AD57-24344BC906FEQ43054525-3075D027-A6E7-420A-8312-77C6627C9731Q43289960-E9A8C9EC-608C-459D-8C25-E0CFDB37B63BQ43355523-85B416BE-E25E-4122-9A05-8D7B0DC6C17BQ45066118-62A5EFA1-3F5E-4513-B9F4-5FAD9E036096Q45927734-6C2ACB8C-B990-4471-BCA1-F27214E69783Q46054326-87C8EAEA-CE89-43E1-8C71-B5E3A39CAB4AQ46108167-3FC401F4-9BC1-48E2-9E39-8F185BA97ED3Q47185076-D693B8C8-3AEB-431F-9004-8D8D0C6A9695Q47188035-08155414-4F09-4D61-B66C-90E2A8F16830Q47194170-B54EFFDC-831D-4A00-95FC-95ABE0ABFAAC
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ana B. Crujeiras
@ast
Ana B. Crujeiras
@en
Ana B. Crujeiras
@es
Ana B. Crujeiras
@nl
Ana B. Crujeiras
@sl
type
label
Ana B. Crujeiras
@ast
Ana B. Crujeiras
@en
Ana B. Crujeiras
@es
Ana B. Crujeiras
@nl
Ana B. Crujeiras
@sl
prefLabel
Ana B. Crujeiras
@ast
Ana B. Crujeiras
@en
Ana B. Crujeiras
@es
Ana B. Crujeiras
@nl
Ana B. Crujeiras
@sl
P106
P1153
13404506000
P21
P31
P496
0000-0003-4392-0301